Shayne Neumann (Blair, Australian Labor Party, Parliamentary Secretary for Health and Ageing) Share this | Hansard source

I seek leave to make an amendment to this private members' motion.

Leave granted.

I move:

That the motion be amended to read—

"That this House:

(1) notes the concerns of key stakeholders in relation to the price reduction of chemotherapy drug Docetaxel and its potential broader impact on the treatment of cancer patients;

(2) notes that the Government:

(a) has announced a review into arrangements for funding chemotherapy services;

(b) is providing $29.7 million in the 2013-14 Budget to pay providers an additional $60 for each chemotherapy infusion on an interim basis for six months, to cover the review period between 1 July 2013 and 31 December 2013, in addition to current fees of $76.37; and

(c) demonstrated it was committed to providing drugs for cancer patients, having added 30 new drugs to treat 15 different cancers at an additional cost of $1.3 billion to the Pharmaceutical Benefits Scheme since 2007; and

(3) welcomes the policy of Accelerated and Expanded Price Disclosure of items on the Pharmaceutical Benefits Scheme"

See this speech in context